Archive of Releases 2021

2021-01-11_Release_New schedule estimate for the CE marking of Company’s ARTEBONE® product
2021-02-01_Release_new_CFO
2021-03-31_Release_Annual_report
2021-04-07 INVITATION TO THE BBS-BIOACTIVE BONE SUBSTITUTES PLC’S ANNUAL GENERAL MEETING (AGM)
2021-04-08 CORRECTION TO THE INVITATION TO THE ANNUAL GENERAL MEETING
2021-04-26 Submission of CE marking application for ARTEBONE® products moves to August
2021-04-28 Decisions of the Annual General Meeting 2021
2021-04-29 CORRECTION Decisions of the Annual General Meeting 2021
BBS_Release_Financial_statements_20210224
25.08.2021 Half-Year Report January 1st –June 30th 2021 (Unaudited)
25.08.2021 CORRECTION: Half-Year Report January 1st –June 30th 2021 (Unaudited)
07.09.2021 Animal test results completed contributing on their part to submitting the CE marking application
30.09.2021 BBS-Bioactive Bone Substitutes Plc has agreed on a capital facility to strengthen the company's working capital – further enables the CE marking application
17.11.2021 Claims of the patent application for the manufacturing of the ARTEBONE® product have been approved in the USA
19.11.2021 Conversion of convertible notes pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc ja Riverfort Global Opportunities PCC Ltd
10.12.2021 Financial calendar and Annual General Meeting in 2022